New Sunscreen Breakthrough: FDA Clears Ingredient Long Used in Europe

The FDA's approval of bemotrizinol marks a pivotal moment for sun care innovation, introducing to American consumers a broad-spectrum UV protectant long available in Europe while addressing key limitations of existing formulations. Unlike current options that block only partial UV rays or leave cosmetically undesirable white residue, bemotrizinol provides comprehensive protection against both UVA and UVB rays with a clear finish. This approval also signals meaningful FDA modernization, as it's the first ingredient approved through a streamlined 2020 Congressional process, suggesting the door may finally be opening for additional sunscreen innovations in the U.S. market.